Rate My Professor Michael Boyle

Michael Boyle's research specializations center on immunology and infectious diseases. His work explores infectious complications of biological and small molecule targeted immunomodulatory therapies, the association between serological diagnosis of coeliac disease and osteoporosis in older adults, autoantibodies and their roles in bone health without clinical autoimmune disease, atherogenesis, inflammation's mediation in depression and cardiovascular hospitalizations, unhealthy lifestyle impacts on depression via inflammation, thyroid antibodies and cognitive decline, epigenetics in multiple sclerosis, asthma inflammation subtypes, and genotyping of urogenital Chlamydia trachomatis. With 41 publications and 3,717 citations documented on his academic profile, key contributions include 'Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies' (2020), 'A Serological Diagnosis of Coeliac Disease Is Associated with Osteoporosis in Older Australian Adults' (2018), 'A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune Disease' (2018), 'A role for autoantibodies in atherogenesis' (2017), 'Chlorhexidine 2% and choice of transparent dressing increase skin reactions at central venous catheter insertion sites' (2016), 'Unhealthy lifestyle may increase later depression via inflammation in older women but not men' (2015), 'Thyroid Antibodies, Autoimmunity and Cognitive Decline: Is There a Population-Based Link?' (2014), and 'Genotyping of Urogenital Chlamydia trachomatis in Regional New South Wales, Australia' (2008). His publications reflect substantial influence in clinical immunology and related public health domains.